Atypical presentation and diagnosis of AIDS-related CMV encephalitis

Erick Kawegere1,2, Tamara Goldberg2,3

  • 1Icahn School of Medicine at Mount Sinai, New York, NY, USA e.kawegere@hotmail.com.

BMJ Case Reports
|August 30, 2022
PubMed

Insights

A man with PTSD developed cytomegalovirus (CMV) encephalitis after drug use. Prompt treatment with ganciclovir led to symptom resolution, highlighting the importance of early diagnosis in immunocompromised patients.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Toxicology

Background:

  • Cytomegalovirus (CMV) encephalitis typically affects immunocompromised individuals.
  • Drug abuse can precipitate opportunistic infections in susceptible populations.

Observation:

  • A middle-aged male with a history of PTSD presented with altered mental status, ataxia, headache, and dizziness post-amphetamine and mushroom use.
  • Neurological examination revealed persistent ataxia and dizziness despite cessation of drug use.
  • Brain imaging (CT and MRI) demonstrated white matter abnormalities in the cerebrum, brainstem, and cerebellum.

Findings:

  • Cerebrospinal fluid analysis confirmed Cytomegalovirus (CMV) infection, leading to a diagnosis of CMV encephalitis.
  • Human Immunodeficiency Virus (HIV) screening revealed a CD4 count of 22, indicating severe immunocompromise.
  • Intravenous ganciclovir treatment resulted in complete symptom resolution.

Implications:

  • This case underscores the potential for drug use to trigger opportunistic infections like CMV encephalitis in undiagnosed HIV-positive individuals.
  • Early diagnosis and treatment of CMV encephalitis are crucial for favorable outcomes, even in complex clinical presentations.
  • Highlights the need for comprehensive screening in patients presenting with neurological symptoms after substance abuse, particularly for underlying immunocompromise.